{
    "title": "Novo Nordisk shares rise as Wegovy shows heart benefits beyond weight loss",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12742751/Novo-Nordisk-shares-rise-Wegovy-shows-heart-benefits-weight-loss.html",
    "date": "2023-11-13",
    "keywords": [
        "heart",
        "wegovy",
        "benefit",
        "maggie",
        "market",
        "loss",
        "august",
        "study",
        "weight",
        "disease",
        "treatment",
        "weightloss",
        "reporting",
        "london",
        "monday",
        "drugmaker",
        "weekend",
        "obesity",
        "drug",
        "saturday",
        "meeting",
        "confidence",
        "day",
        "trial",
        "average",
        "incidence",
        "attack",
        "death",
        "risk",
        "difference",
        "semaglutide",
        "markus",
        "portfolio",
        "manager",
        "union",
        "investment",
        "germany",
        "shareholder",
        "surprise",
        "differentiator",
        "amgen",
        "pfizer",
        "note",
        "data",
        "cost",
        "medicine",
        "price",
        "month",
        "approval",
        "bill",
        "july",
        "medicare",
        "health",
        "plan",
        "law",
        "part",
        "class",
        "gut",
        "hormone",
        "blood",
        "sugar",
        "food",
        "beverage",
        "investor",
        "impact",
        "popularity",
        "novo",
        "week",
        "lillys",
        "mounjaro",
        "close",
        "year",
        "fick",
        "boleslaw",
        "medha",
        "singh",
        "bengaluru",
        "editing",
        "louise",
        "fahmy"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}